文献速递主动脉疾病

开窗与分支腔内主动脉修复术后夹层后主动脉瘤囊扩张

Postdissection aortic aneurysm sac enlargement after fenestrated and branched endovascular aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2024-06-21

本研究分析了10项医生发起的器械豁免研究中2008至2023年间因夹层后胸腹主动脉瘤接受开窗-分支腔内修复术的290例患者,平均随访2.9年,15%出现瘤囊扩张,年龄>70岁和1年时II型内漏为独立预测因素,瘤囊扩张未影响患者生存。

要点

  • 夹层后胸腹主动脉瘤开窗-分支腔内修复术后15%患者出现瘤囊扩张。
  • 年龄>70岁和1年时II型内漏是瘤囊扩张的独立预测因素。
  • 瘤囊扩张未影响患者生存,5年动脉瘤相关死亡率为2%。

核心结论

  • 夹层后胸腹主动脉瘤开窗-分支腔内修复术后15%患者出现瘤囊扩张,年龄>70岁和1年时II型内漏为独立预测因素,瘤囊扩张未影响患者生存。

研究设计与样本

  • 分析2008至2023年10项医生发起的器械豁免研究中因夹层后胸腹主动脉瘤行开窗-分支腔内主动脉修复术的290例患者(72.4%男性,中位年龄68.4岁)。

主要发现

  • 平均动脉瘤直径66.5±11.2 mm,30天死亡率为1.4%。
  • 平均随访2.9±1.9年,43例(15%)瘤囊扩张,115例(40%)瘤囊回缩,137例(47%)无扩张也无回缩,5例(2%)随访中同时出现扩张和回缩。
  • 免于瘤囊扩张率1年93%、3年82%、5年80%。
  • 瘤囊扩张组27例(63%)检出内漏,无扩张组143例(58%)检出内漏(P=.54)。
  • 瘤囊扩张患者年龄更大(70.2±8.9岁 vs 66.5±11岁;P=.04),1年时II型内漏更常见(74% vs 52%;P=.031)。

临床怎么用

  • 作者认为,老年患者(基线>70岁)和1年时存在II型内漏者可能需要更密切监测和二次干预以预防瘤囊扩张。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aneurysm sac changes after fenestrated-branched endovascular aneurysm repair (FBEVAR) for postdissection thoracoabdominal aortic aneurysms (PD-TAAs) are poorly understood. Partial thrombosis of the false lumen and endoleaks may impair sac regression. To characterize sac changes after FBEVAR for PD-TAAs, this study examined midterm results and predictors for sac enlargement. METHODS: FBEVARs performed for PD-TAAs in 10 physician-sponsored investigational device exemption studies from 2008 to 2023 were analyzed. The maximum aortic aneurysm diameter was compared between the 30-day computed tomography angiogram and follow-up imaging studies. Aneurysm sac enlargement was defined as an increase in diameter of ≥5 mm. Kaplan-Meier curves and Cox regression were used to evaluate sac enlargement and midterm FBEVAR outcomes. RESULTS: Among 3296 FBEVARs, 290 patients (72.4% male; median age, 68.4 years) were treated for PD-TAAs. Most aneurysms treated were extent II (72%) and III (12%). Mean aneurysm diameter was 66.5 ± 11.2 mm. Mortality at 30 days was 1.4%. At a mean follow-up of 2.9 ± 1.9 years, at least one follow-up imaging study revealed sac enlargement in 43 patients (15%), sac regression in 115 patients (40%), and neither enlargement nor regression in 137 (47%); 5 (2%) demonstrated both expansion and regression during follow-up. Freedom from aneurysm sac enlargement was 93%, 82%, and 80% at 1, 3, and 5 years, respectively. Overall, endoleaks were detected in 27 patients (63%) with sac enlargement and 143 patients (58%) without enlargement (P = .54). Sac enlargement was significantly more frequent among older patients (mean age at the index procedure, 70.2 ± 8.9 years vs 66.5 ± 11 years; P = .04) and those with type II endoleaks at 1 year (74% vs 52%; P = .031). Cox regression revealed age >70 years at baseline (hazard ratio [HR], 2.146; 95% confidence interval [CI], 1.167-3.944; P = .010) and presence of type II endoleak at 1 year (HR, 2.25; 95% CI, 1.07-4.79; P = .032) were independent predictors of sac enlargement. Patient survival was 92%, 81%, and 68% at 1, 3, and 5 years, respectively. Cumulative target vessel instability was 7%, and aneurysm-related mortality was 2% at 5 years. At least 42% of patients required secondary interventions. Sac enlargement did not affect patient survival. CONCLUSIONS: Aneurysm sac enlargement occurs in 15% of patients after FBEVAR for PD-TAAs. Elderly patients (>70 years at baseline) and those with type II endoleaks at 1 year may need closer monitoring and secondary interventions to prevent sac enlargement. Despite sac enlargement in some patients, aneurysm-related mortality at 5 years remains low and overall survival was not associated with sac enlargement.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Figueroa AV, Tanenbaum MT, Timaran CH, et al. Postdissection aortic aneurysm sac enlargement after fenestrated and branched endovascular aortic aneurysm repair. J Vasc Surg. 2024. PMID: 38909915. doi:10.1016/j.jvs.2024.04.066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。